Company News
Poly Medicure Q4FY24 results: PAT jumps 16.24%, revenue up 23.21%
Poly Medicure has announced Q4FY24 results. PAT grew 16.24% to Rs 68.36 crore in Q4 FY24 as against Rs 58.81 crore in Q4 FY23.
Revenue rose 23.21% to Rs 378.07 crore in Q4 FY24 as against Rs 306 in Q4FY23.
Total expenses in Q4 FY24 stood at Rs 300.82 crore, up 24.94% YoY.
FY24 highlights:
Net profit jumped 44.05% to Rs 258.26 crore. Revenue rose 23.36% to Rs 1,375.8 crore in FY24
Poly Medicure board has recommended a dividend of Rs 3 per equity share for the financial year 2023-24, subject to the approval of shareholders.
Poly Medicure exports plastic medical disposables/surgical devices. It manufactures and supplies disposable medical devices in the product verticals of infusion therapy, anesthesia, urology, gastroenterology, blood management, blood collection, surgery and wound drainage, dialysis, and central venous access catheters.
MB Bureau